Related Experiment Videos
Interventional therapies for heart failure in the elderly
Srihari S Naidu1, S Chiu Wong, Richard M Steingart
1Weill Medical College of Cornell University, 130 York Avenue, New York, NY 10021, USA.
Insights
The aging US population faces a heart failure (HF) epidemic due to prevalent risk factors. This review updates interventional therapies for elderly HF patients with diverse underlying causes.
Area of Science:
- Cardiology
- Geriatrics
- Interventional Medicine
Background:
- The US population is aging, leading to increased prevalence of heart failure (HF).
- Existing risk factors like coronary heart disease, diabetes, and hypertension exacerbate HF incidence.
- Despite medical advances, symptomatic HF patients experience significant morbidity and mortality.
Purpose of the Study:
- To provide an updated review of interventional therapies for heart failure in elderly patients.
- To address HF stemming from various etiologies including coronary artery, valvular, congenital, myocardial, and renal vascular diseases.
Main Methods:
- Literature review focusing on interventional treatments for elderly heart failure patients.
- Analysis of current therapeutic strategies for diverse HF causes.
Main Results:
- Maximal medical therapy alone is insufficient for many symptomatic HF patients.
- Interventional therapies offer potential treatment options for specific HF etiologies in the elderly.
Conclusions:
- Interventional therapies are crucial for managing heart failure in the aging US population.
- Further research and application of these therapies are needed to improve outcomes for elderly HF patients.
Abstract:
The aging of a population replete with risk factors for heart failure(HF) (coronary heart disease, diabetes, and hypertension) coupled with a declining age-adjusted mortality rate for coronary artery and hypertensive heart diseases has created, and will continue to create, a literal explosion in the prevalence of HF in the United States. Despite advances in maximal medical therapy, however, most patients who have symptomatic HF can expect functional impairment, interludes of worsening symptomatology, and a shortened lifespan. This article updates the use of interventional therapies for the treatment of elderly patients who have HF caused by coronary artery disease, valvular heart disease, congenital heart disease, myocardial disease, and renal vascular disease.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents